ADVFN US – Market Content Editor
-

Dover tops Q4 forecasts as organic growth accelerates, shares advance
Dover Corporation (NYSE:DOV) delivered fourth-quarter results that came in ahead of market expectations, supported by broad-based strength across its operating segments. The company’s shares were up about 1.5% in pre-market trading after the announcement. Adjusted earnings per share for the quarter reached $2.51, edging past analysts’ forecasts of $2.49. Revenue totaled $2.1 billion, slightly above…
-

Fractyl Health shares slide after interim GLP-1 weight-maintenance data
Fractyl Health (NASDAQ:GUTS) shares plunged around 35% after the company released six-month randomized midpoint data from its REMAIN-1 trial studying Revita as a weight-maintenance therapy following discontinuation of GLP-1 drugs. The company said patients treated with Revita regained 4.5% of body weight at six months, compared with 7.5% in the sham group, suggesting some moderation…
-

Altria posts steady Q4 profit, sets out 2026 outlook
Altria Group (NYSE:MO) reported fourth-quarter adjusted earnings that were unchanged from a year earlier, coming in at $1.30 per share and just below analysts’ expectations of $1.32. Revenue net of excise taxes slipped 0.5% to $5.08 billion, but still came in ahead of the $5.02 billion consensus forecast. Shares of the tobacco group eased 0.21%…
-

Comcast beats Q4 profit forecasts, shares edge higher
Comcast (NASDAQ:CMCSA) reported fourth-quarter earnings that came in ahead of market expectations, supported by stronger profitability, while revenue landed broadly in line with forecasts. The group posted earnings per share of $0.84 for the quarter, comfortably above the consensus estimate of $0.73. Revenue totaled $32.31 billion, essentially matching market expectations of $32.35 billion. Comcast shares…
-

Unicycive shares gain as FDA accepts resubmitted OLC NDA
Unicycive Therapeutics (NASDAQ:UNCY) shares climbed about 3% on Thursday after the company said the U.S. Food and Drug Administration has accepted the resubmission of its New Drug Application for oxylanthanum carbonate (OLC). The FDA classified the filing as a Class II complete response, triggering a six-month review timeline and setting a Prescription Drug User Fee…
-

A.O. Smith beats Q4 profit expectations, unveils 2026 outlook
A.O. Smith Corporation (NYSE:AOS) reported fourth-quarter results on Thursday that came in ahead of market expectations on earnings, even as revenue fell slightly short of forecasts. The water technology group delivered earnings per share of $0.90 for the quarter, topping the consensus estimate of $0.84 by six cents. Shares were little changed following the release.…
-

Tractor Supply shares slide nearly 6% after Q4 earnings miss
Tractor Supply Company (NASDAQ:TSCO) shares dropped sharply on Thursday after the retailer reported fourth-quarter results that came in below market expectations, pointing to softer consumer spending on discretionary items. The stock was down 5.69% in pre-market trading following the update. Tractor Supply posted fourth-quarter earnings of $0.43 per share, missing analysts’ forecasts of $0.47. Revenue…
-

AMC shares climb after lender deal opens door to debt refinancing
AMC Entertainment (NYSE:AMC) shares gained 2.8% on Thursday after the cinema operator said it had reached an agreement with lenders that gives it greater flexibility to refinance portions of its existing debt. The deal, struck with certain holders of AMC’s Muvico, LLC Senior Secured Notes due 2029, allows the company to pursue refinancing of its…
-

USA Rare Earth Closes $1.5 Billion PIPE to Fund Integrated Growth Strategy
USA Rare Earth Inc. (NASDAQ:USAR) said it has finalized a private investment in public equity (PIPE) transaction, securing roughly $1.5 billion in gross proceeds to support its long-term expansion plans. The fundraising was anchored by Inflection Point and drew additional backing from a group of fundamental and strategic investors. As part of the deal, the…
-

MarineMax Slides as Q1 Earnings Shortfall Dims Strong Sales Growth
MarineMax, Inc. (NYSE:HZO) reported first-quarter fiscal 2026 results on Thursday that fell short of profit expectations, overshadowing a solid revenue beat and prompting a pullback in the shares. The stock dropped 3.16% in pre-market trading following the announcement. For the quarter ended December 31, 2025, MarineMax posted an adjusted loss of -$0.21 per share, wider…